Japan’s MetaPlanet Secures Massive $100M Bitcoin-Backed Loan - Institutional Adoption Accelerates

Tokyo-based MetaPlanet locks in nine-figure financing using Bitcoin as collateral—signaling mainstream acceptance of crypto assets.

The Strategic Pivot

MetaPlanet's $100 million loan backed entirely by Bitcoin holdings demonstrates how traditional finance finally embraces what crypto enthusiasts knew for years—digital assets represent legitimate collateral. The move follows similar treasury strategies by MicroStrategy and Tesla, creating a new corporate playbook for leveraging crypto holdings.

Institutional Validation

Lenders accepting Bitcoin as primary collateral marks a watershed moment. No longer treating crypto as speculative toys, financial institutions now recognize Bitcoin's value as loan security—though it only took them a decade to catch up with what retail investors understood back in 2017.

Corporate Treasury 2.0

Companies worldwide watch as MetaPlanet leverages its Bitcoin position without selling—proving hodling strategy works for corporations too. The $100 million infusion shows how crypto-native companies can access capital markets while maintaining exposure to digital asset appreciation.

As traditional finance slowly rediscovers secured lending—this time with digital assets—one wonders if banks will finally stop treating Bitcoin like it's 2013. The $100 million question: who's next to unlock their crypto treasury value?

TLDR

• Onassis Holdings appointed Esq. Paz Itzhaki-Weinberger to its Advisory Board.
• He will oversee international law, trade, and corporate affairs.
• Itzhaki-Weinberger has experience with Microsoft and global law firms.
• He currently serves as CEO and Chairman of IWC Limited.
• The move supports Onassis Holdings’ biotechnology expansion strategy.

Onassis Holdings Corp. (OTC: ONSS) announced the appointment of Esq. Paz Itzhaki-Weinberger to its Advisory Board. The MOVE aims to strengthen the company’s global governance and legal strategies as it expands its footprint in cellular rejuvenation and longevity biotechnology.

Strengthening International Legal and Trade Strategy

Under his new role, Itzhaki-Weinberger will lead Onassis Holdings’ initiatives across international law, trade, and cross-border corporate affairs. The company said his multidisciplinary background WOULD be instrumental in navigating complex global regulatory frameworks as Onassis accelerates its research partnerships and international collaborations.

Itzhaki-Weinberger brings extensive experience spanning technology, legal practice, and global business strategy. His appointment underscores Onassis Holdings’ focus on building a resilient and internationally compliant corporate structure to support its biotechnology innovations.

Diverse Expertise in Law and Technology

A seasoned leader, Paz Itzhaki-Weinberger has held senior roles at Microsoft Corporation and managed multiple high-tech ventures, bridging engineering expertise with legal and business acumen.

He founded PIWLAW, a firm recognized among the Top 200 Law Firms Worldwide (2014–2025) by Legals Finest. His practice covers areas including intellectual property, corporate law, and international arbitration, making him a strategic fit for Onassis Holdings’ growing portfolio of biotech patents and cross-border collaborations.

Itzhaki-Weinberger holds degrees in Computer Science and Law and is fluent in English, Hebrew, Japanese, German, and Arabic, allowing him to operate seamlessly across diverse markets.

Global Affiliations and Leadership Roles

Beyond his professional practice, Itzhaki-Weinberger is CEO and Chairman of IWC Limited and has previously led PatentsFund.com, providing advisory support to technology companies on IPO and M&A transactions.

He is affiliated with leading professional bodies including the Israel Bar Association, American Bar Association International Law Division, and The Law Society of England and Wales. He also serves as a Senior Member of IEEE and a board member of the Israel-Britain Chamber of Commerce, reflecting his active engagement in global technology and legal networks.

About Onassis Holdings Corp.

Onassis Holdings Corp. (OTC: ONSS) is a U.S.-based public biotechnology company focused on cellular rejuvenation and longevity research. The firm leverages world-class scientific collaborations to drive advancements in regenerative medicine, targeting breakthroughs that extend healthy human lifespan.

Through strategic appointments such as this, Onassis aims to bolster its international operations and align its governance structure with its long-term innovation roadmap.

By integrating Itzhaki-Weinberger’s cross-border expertise, Onassis Holdings positions itself for sustainable global growth and regulatory agility in a rapidly evolving biotech landscape.